Heart Rate Variability (HRV): When to Order This Test

What HRV Actually Measures

Heart rate variability quantifies the time gaps between successive R-R intervals on an electrocardiogram. A heart beating at exactly 60 bpm does not fire every 1,000 ms like a clock. The intervals shift, sometimes 980 ms, sometimes 1,040 ms. That variation is the signal.

The 1996 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology published the foundational standards for HRV measurement, dividing metrics into time-domain, frequency-domain, and nonlinear categories [1]. Time-domain measures like SDNN and RMSSD remain the most clinically validated. SDNN captures overall autonomic variability across a recording period, while RMSSD isolates beat-to-beat changes driven primarily by vagal (parasympathetic) activity [1]. Frequency-domain analysis separates the signal into low-frequency (LF, 0.04 to 0.15 Hz) and high-frequency (HF, 0.15 to 0.40 Hz) bands, with the HF component reflecting vagal modulation of the sinus node [2].

Short recordings (5 minutes) suit clinical screening and wearable-based monitoring. Full 24-hour Holter recordings provide the reference standard for SDNN, and the two durations are not interchangeable. A 5-minute SDNN of 40 ms means something different from a 24-hour SDNN of 40 ms. Clinicians must compare values only within the same recording length [1].

When to Order an HRV Test

Order HRV testing when clinical suspicion points to autonomic dysfunction, when stratifying cardiac risk after an acute event, or when tracking recovery in patients with known metabolic disease. The test is not a routine screening lab. It answers specific questions.

Post-myocardial infarction risk stratification. The ATRAMI trial (N=1,284) demonstrated that patients with depressed HRV (SDNN <70 ms) after MI had a significantly higher risk of cardiac mortality, independent of left ventricular ejection fraction [3]. The American College of Cardiology and American Heart Association recognize HRV as a supplementary risk marker in post-MI evaluation [4]. A 24-hour Holter with HRV analysis within 1 to 2 weeks post-discharge can identify patients who may benefit from closer follow-up or more aggressive beta-blocker titration.

Diabetic cardiac autonomic neuropathy (CAN). The American Diabetes Association recommends screening for CAN in patients with type 2 diabetes at diagnosis and in type 1 diabetes after 5 years of disease duration [5]. Reduced HRV is among the earliest detectable signs of CAN, often preceding symptoms like resting tachycardia or orthostatic hypotension by years. The Toronto Consensus Panel on Diabetic Neuropathy identified time-domain HRV analysis as a validated method for CAN detection, requiring at least two abnormal cardiovascular autonomic reflex tests for a definitive diagnosis [6].

Heart failure monitoring. In the Val-HeFT trial (N=5,010), every 10-ms decrease in SDNN among patients with chronic heart failure was associated with a 3.2% increase in the risk of mortality or first morbidity event [7]. Serial HRV tracking can signal worsening autonomic imbalance before clinical decompensation becomes obvious.

Overtraining and recovery assessment. Sports medicine physicians order short-term HRV recordings (often morning, supine, 5-minute RMSSD) to distinguish between functional overreaching and non-functional overtraining syndrome. A sustained RMSSD drop exceeding 15% from an athlete's personal baseline, lasting more than 7 days, may indicate maladaptive stress that warrants a deload period [8].

Normal HRV Ranges by Age

A "normal" HRV number depends on the metric used, the recording length, and the patient's age. Raw values without this context are clinically meaningless.

For 24-hour SDNN in healthy adults, the 1996 Task Force data and subsequent validation studies suggest these approximate ranges by decade [1][9]:

Ages 20 to 29: SDNN 140 to 170 ms. Ages 30 to 39: SDNN 120 to 150 ms. Ages 40 to 49: SDNN 100 to 130 ms. Ages 50 to 59: SDNN 90 to 120 ms. Ages 60 to 69: SDNN 70 to 100 ms. Ages 70 and above: SDNN 50 to 90 ms.

These ranges carry wide inter-individual variability. A 55-year-old endurance athlete may have an SDNN exceeding 150 ms, while a sedentary 30-year-old with untreated sleep apnea might measure below 80 ms. The clinical value lies not in a single snapshot but in trends over time and in context. Dr. George Billman, a cardiac electrophysiologist at The Ohio State University, wrote in Frontiers in Physiology: "HRV is not a single number but rather a family of indices, each reflecting different aspects of autonomic regulation. Interpretation requires knowledge of the recording conditions, the analytical method, and the patient's clinical status" [10].

What a High HRV Means

Higher HRV generally reflects strong parasympathetic tone and adaptive autonomic flexibility. It signals that the heart can respond efficiently to changing demands, slowing during rest and accelerating during exertion.

In population studies, elevated HRV correlates with lower cardiovascular mortality. The Framingham Heart Study analysis (N=2,501) found that each standard deviation increase in log-transformed HF power was associated with a 17% reduction in the risk of cardiac events over a 3.5-year follow-up [11]. Young, fit, well-rested individuals typically display the highest readings.

An important exception exists. Very high HRV in certain patterns can indicate pathology rather than health. Exaggerated respiratory sinus arrhythmia occasionally reflects vagal hyperactivity, which may present clinically as vasovagal syncope or profound bradycardia. Some antiarrhythmic medications and conditions like sick sinus syndrome can produce misleadingly high beat-to-beat variation that does not represent cardiovascular fitness [2]. Context and clinical correlation matter.

What a Low HRV Means

Low HRV reflects reduced vagal tone, sympathetic dominance, or both. The clinical significance depends on how low and why.

An SDNN below 50 ms on a 24-hour recording is a well-established marker of increased mortality risk. The UK-Heart study (N=433 patients with chronic heart failure) showed that SDNN <50 ms predicted a 51% 2-year mortality rate compared to 6% in patients with SDNN above 100 ms [12]. That is an 8.5-fold difference. Dr. Marek Malik, who chaired the 1996 Task Force panel, noted in the European Heart Journal: "SDNN values below 50 ms after myocardial infarction classify a patient into the highest risk category, comparable in predictive power to severe left ventricular dysfunction" [1].

Common causes of reduced HRV include chronic psychological stress, physical deconditioning, obesity, diabetes, sleep deprivation, chronic pain syndromes, and medications such as anticholinergics and certain antidepressants (tricyclics in particular). Acute illness, including systemic infections, can suppress HRV transiently. In sepsis, depressed HRV has been studied as a predictor of multiple organ dysfunction and ICU mortality [13].

Not every low reading signals danger. A single 5-minute recording taken after caffeine intake, a poor night of sleep, or during acute anxiety may show suppressed RMSSD without indicating chronic autonomic impairment. Serial measurement under consistent conditions (same time of day, same body position, same pre-recording routine) improves clinical reliability.

How to Improve Low HRV

Improving HRV requires addressing the underlying cause. No supplement or breathing exercise will override untreated obstructive sleep apnea or uncontrolled type 2 diabetes.

Aerobic exercise. A 2018 meta-analysis of 21 randomized controlled trials (total N=834) published in Sports Medicine found that regular aerobic training increased RMSSD by an average of 4.2 ms and SDNN by 6.4 ms over intervention periods of 4 to 24 weeks [14]. Effects were more pronounced in sedentary individuals than in already-trained athletes. The dose-response relationship favored moderate-intensity continuous training (65 to 75% of maximum heart rate) performed 3 to 5 times per week.

Sleep optimization. Short sleep duration (<6 hours) and poor sleep quality both correlate with reduced nocturnal HRV. Treatment of obstructive sleep apnea with CPAP has been shown to increase HRV indices within 3 months of consistent use [15].

Stress reduction techniques. Slow-paced breathing at approximately 6 breaths per minute (resonance frequency breathing) acutely increases HF-HRV by stimulating the baroreflex. A 2021 randomized trial (N=100) published in Applied Psychophysiology and Biofeedback demonstrated that 4 weeks of daily 20-minute resonance breathing practice increased resting RMSSD by 9.8 ms compared to controls [16].

Medication review. Anticholinergic medications suppress parasympathetic output. Beta-blockers, conversely, may improve HRV by reducing sympathetic dominance, as shown in the ATRAMI post-MI cohort where beta-blocker use correlated with higher SDNN values [3].

Weight management. Adiposity independently suppresses vagal tone. In a study of 60 obese adults published in Obesity Research, a 10% reduction in body weight over 6 months improved SDNN by an average of 14 ms [17].

How HRV Relates to Other Lab and Diagnostic Tests

HRV does not exist in isolation. Clinicians interpreting autonomic function typically order complementary assessments to build a complete picture.

Resting heart rate. A high resting heart rate with low HRV suggests sympathetic overdrive. A normal resting heart rate with low HRV can still indicate parasympathetic withdrawal that has been partially compensated.

Orthostatic vital signs and tilt-table testing. These provocation tests assess the cardiovascular reflex arc directly and help confirm autonomic neuropathy suspected on HRV analysis. The Ewing battery of cardiovascular reflex tests (deep breathing, Valsalva, standing) complements HRV data in the CAN workup recommended by the American Diabetes Association [5][6].

Fasting glucose and HbA1c. Because diabetic CAN is a primary indication for HRV testing, concurrent metabolic labs confirm glycemic status. An HbA1c above 7.0% sustained over years increases the probability that reduced HRV reflects neuropathic damage rather than a transient stressor.

Cortisol and DHEA-S. Chronic HPA-axis dysregulation from prolonged stress can suppress vagal tone. Morning cortisol, diurnal cortisol curves, or salivary cortisol panels can help differentiate stress-mediated HRV suppression from structural autonomic disease.

NT-proBNP and echocardiography. In heart failure patients, pairing HRV analysis with natriuretic peptide levels and structural imaging helps distinguish autonomic decline due to worsening heart failure from other causes.

Wearable HRV vs. Clinical-Grade HRV

Consumer wearables (Apple Watch, Whoop, Oura Ring, Garmin) now report HRV metrics, primarily RMSSD from photoplethysmography sensors. These are not the same as electrocardiogram-derived values, and direct numerical comparison between a wearable reading and a Holter-derived SDNN is not valid.

Wearable HRV data can be useful for tracking intra-individual trends. If a patient's 30-day RMSSD average drops from 45 ms to 28 ms on a Whoop band, that trend has clinical relevance even though the absolute numbers are not directly comparable to ECG-derived values. A 2020 validation study published in Sensors compared RMSSD from the Apple Watch Series 4 against a standard 3-lead ECG in 20 healthy adults and found a mean absolute error of 5.2 ms and an intraclass correlation coefficient of 0.87, suggesting acceptable relative agreement for trend monitoring [18].

The limitation is context control. Wearable recordings occur at variable times, in variable positions, with variable pre-recording activity. For clinical decision-making (post-MI stratification, CAN diagnosis), ECG-based recording under standardized conditions remains the reference standard [1].

Who Should Not Rely on HRV Testing Alone

HRV is a supplementary marker, not a standalone diagnostic. Patients with atrial fibrillation produce irregular R-R intervals that make standard HRV analysis unreliable. Frequent premature ventricular contractions (PVCs exceeding 5% of total beats) can artificially inflate or suppress SDNN depending on the ectopy correction algorithm used [1]. Pacemaker-dependent patients generate fixed-rate intervals that eliminate physiologic variability entirely.

In these populations, alternative autonomic assessments (tilt-table testing, sudomotor function testing, or cardiac MIBG scintigraphy) provide more reliable information about autonomic integrity.